PhysiologybioRxiv
Impaired Therapeutic Efficacy of Bone Marrow Cells from Post-Myocardial Infarction Patients in the TIME and LateTIME Clinical Trials
X. Wang, R. Derakhshandeh, H. J. Rodriguez…·M. L. Springer
The paper tests if post-MI human MNCs from clinical trials show impaired therapeutic efficacy compared to healthy donor MNCs in mouse models, finding no therapeutic benefit in either TIME or LateTIME patient MNCs.
DOI 10.1371/journal.pone.0237401